1. A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer. Issue 4 (April 2022) Authors: Lerner, A.; Keshwani, K.; Okines, A.; Sanderson, B.; Board, R.E.; Flynn, M.; Sharkey, E.; Konstantis, A.; Roylance, R.; Hanna, D.; King, J.; Murphy, R.; Rehman, F.; Guppy, A.E.; Westbury, C.; Takeuchi, E.; Spurrell, E.; Jayaweera, H.K.; Raja, F. Journal: Clinical oncology Issue: Volume 34:Issue 4(2022) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant Chemotherapy for Breast Cancer in Older Women. Issue 8 (August 2016) Authors: Spurrell, E.; Wilson, P.; Gallagher, C.; Slater, S.; Roylance, R. Journal: Clinical oncology Issue: Volume 28:Issue 8(2016) Page Start: 542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Is Universal Patient Access to Fulvestrant in Hormone Receptor-positive Advanced Breast Cancer Justified? A UK Retrospective Multicentre Study. Issue 8 (August 2020) Authors: Lerner, A.; Keshwani, K.; Sanderson, B.; Board, R.E.; Flynn, M.; Sharkey, E.; Okines, A.; Konstantis, A.; Roylance, R.; Hanna, D.; King, J.; Murphy, R.; Rehman, F.; Guppy, A.; Westbury, C.; Takeuchi, E.; Spurrell, E.; Raja, F. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: e167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neoadjuvant endocrine treatment and clinical outcome in ER positive breast cancer – a single UK cancer centre experience. (October 2020) Authors: Benafif, S.; Rapti, K.; Nattress, C.; Akay, M.; Roylance, R.; Raja, F.; Spurrell, E.; Konstantis, A.; Papadimitraki, E. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗